Influence of anticholinergic-antiparkinsonian agents on the effects of narcoanalgesic drugs in the rat.
D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D001362:Avoidance Learning / Q000187:drug effects; D001712:Biperiden / Q000494:pharmacology; D003517:Cyclopentanes / Q000494:pharmacology; D004357:Drug Synergism; D004361:Drug Tolerance / Q000187:drug effects; D005021:Ethylamines / Q000494:pharmacology; D008297:Male; D008614:Meperidine / Q000494:pharmacology*; D009020:Morphine / Q000494:pharmacology*; D010276:Parasympatholytics / Q000494:pharmacology*; D010640:Phenothiazines / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D051381:Rats
D000978:Antiparkinson Agents; D003517:Cyclopentanes; D005021:Ethylamines; D010276:Parasympatholytics; D010640:Phenothiazines; D010880:Piperidines; D001712:Biperiden; D009020:Morphine; D001285:Atropine; D008614:Meperidine